Wambolt & Associates, LLC / ABBV
Wambolt & Associates, LLC’s Abbvie Inc Position
Does Wambolt & Associates, LLC own Abbvie Inc (ABBV)? Yes — 20.8K shares worth $4M (+1.33% of its 13F portfolio) as of Q2 2025, down from 22.3K shares the prior filed quarter.
Position Value
$4M
Q2 2025
Shares
20.8K
% of Portfolio
+1.33%
Quarters Held
27
currently held
Position History ABBV
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2025 | 20.8K | $4M | +1.33% |
| Q1 2025 | 22.3K | $5M | +1.56% |
| Q4 2024 | 23.9K | $4M | +1.36% |
| Q3 2024 | 29.1K | $6M | +1.56% |
| Q2 2024 | 28.5K | $5M | +1.41% |
| Q1 2024 | 27.5K | $5M | +1.49% |
| Q4 2023 | 27.4K | $4M | +1.39% |
| Q3 2023 | 27.1K | $4M | +1.46% |
| Q2 2023 | 26.4K | $4M | +1.27% |
| Q1 2023 | 26.5K | $4M | +1.51% |
| Q4 2022 | 25.9K | $4M | +1.61% |
| Q3 2022 | 25.5K | $3M | +1.45% |
| Q2 2022 | 25.4K | $4M | +1.56% |
| Q1 2022 | 24.7K | $4M | +1.46% |
| Q4 2021 | 23.1K | $3M | +1.13% |
| Q3 2021 | 22.1K | $2M | +0.97% |
| Q2 2021 | 20.0K | $2M | +0.97% |
| Q1 2021 | 17.7K | $2M | +1.00% |
| Q4 2020 | 15.0K | $2M | +0.96% |
| Q3 2020 | 12.8K | $1M | +0.84% |
| Q2 2020 | 10.1K | $992,000 | +0.78% |
| Q1 2020 | 8.2K | $628,000 | +0.65% |
| Q4 2019 | 5.7K | $503,000 | +0.38% |
| Q3 2019 | 5.7K | $430,000 | +0.36% |
| Q2 2019 | 5.9K | $429,000 | +0.36% |
| Q1 2019 | 5.0K | $412,000 | +0.37% |
| Q4 2018 | 5.1K | $473,000 | +0.52% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Wambolt & Associates, LLC’s full portfolio or all institutional holders of ABBV.